First Time Loading...

ChemPartner PharmaTech Co Ltd
SZSE:300149

Watchlist Manager
ChemPartner PharmaTech Co Ltd Logo
ChemPartner PharmaTech Co Ltd
SZSE:300149
Watchlist
Price: 5.08 CNY -0.2%
Updated: May 23, 2024

ChemPartner PharmaTech Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ChemPartner PharmaTech Co Ltd
Operating Income Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
ChemPartner PharmaTech Co Ltd
SZSE:300149
Operating Income
-¥920.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Operating Income
-¥8.8B
CAGR 3-Years
8%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Operating Income
-¥1.5B
CAGR 3-Years
-51%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Operating Income
¥1.4B
CAGR 3-Years
22%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Operating Income
¥8.7B
CAGR 3-Years
25%
CAGR 5-Years
34%
CAGR 10-Years
53%
Imeik Technology Development Co Ltd
SZSE:300896
Operating Income
¥1.4B
CAGR 3-Years
59%
CAGR 5-Years
72%
CAGR 10-Years
N/A

See Also

What is ChemPartner PharmaTech Co Ltd's Operating Income?
Operating Income
-920.8m CNY

Based on the financial report for Mar 31, 2024, ChemPartner PharmaTech Co Ltd's Operating Income amounts to -920.8m CNY.

What is ChemPartner PharmaTech Co Ltd's Operating Income growth rate?
Operating Income CAGR 1Y
-38%

Over the last year, the Operating Income growth was -38%.